Conditions: Epilepsy Generalized Tonic-clonic Seizures
Keywords: Levetiracetam Epilepsy Generalized tonic-clonic seizures
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 44
Healthy volunteers: no

Brief summary:
The investigators will provide Levetiracetam treatment to epilepsy subjects in Japan who are judged to benefit from continued treatment with Levetiracetam by the investigators and who are willing to continuously receive this drug.

Detailed description:

Arms:
arm 1: Twice daily (morning and evening) orally

Interventions: intervention 1: Levetiracetam
Intervention descriptions: intervention 1: formulation: tablet or dry syrup

strength: 250 mg tablet, 500 mg tablet, dry syrup 50%

dosage: Sb ≥16 years and ≥4 and \<16 years (≥50 kg): 1000 mg/day, 2000 mg/day or 3000 mg/day; Sb ≥4 and \<16 years (\<50kg): 20 mg/kg/day, 40 mg/kg/day, or 60 mg/kg/day

frequency: twice daily

Protocol document: